Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
al-Dakan AA, al-Tuffail M, Hannan MA (1995) Cassia senna inhibits mutagenic activities of benzo [α]-pyrene, aflatoxin B1, shamma and methyl methansulfonate. Pharmacol Toxicol 77: 288–292
Anderson AS (1986) Dietary factors in the etiology and treatment of constipation during pregnancy. Br J Obstet Gynaecol 93: 245–249
Andorsky RI, Major MD, Goldner F (1990) Colonic lavage solution (polyethylene glycol electrolyte lavage solution) as a treatment for chronic constipation: a double-blind, placebo-controlled study. Am J Gastroenterol 85: 261–265
Autore G, Capasso F, Mascolo N (1984) Phenolphthalein stimulates the formation of histamine, 5-hydroxytryptamine and prostaglandin-like material by rat jejunum, ileum and colon. Br J Pharmacol 81: 347–349
Autore G, Caliendo G, Pepe A, Capasso F (1990a) Perfusion of rat colon with sennosides, rhein and rheinanthrone. Dose related histamine release. Eur J Pharmacol 191: 97–99
Autore G, Calignano A, Mascolo N, Capasso F (1990b) Role of kinins in the laxation induced by castor oil. Pharmacol Life Sci Adv 9: 51–54
Badiali D, Marcheggiano A, Pallone S, Paoluzi T, Rausano G, Jannoni C, Materia E, Anzini S, Corazziari E (1985) Melanosis of the rectum in patients with chronic constipation. Dis Colon Rectum 28: 241–245
Balaa MA, Powell DW (1986) Prostaglandin synthesis by enterocyte microsomes of rabbit small intestine. Prostaglandins 31: 609–624
Balasz M (1986) Melanosis coli. Ultrastructural study of 45 patients. Dis Colon Rectum 29: 839–844
Baldwin WF (1963) Clinical study of senna administration to nursing mothers. Assessment of effects on infants bowel habits. Can Med Assoc J 89: 566–568
Bardon T, Deragnauncourt J (1985) Effects of platelet activating factor (PAF) on the digestive mobility in the conscious rat. Dig Dis Sci 30: 738–765
Bauer H (1977) Behandlung der Obstipation mit Laxantien in der gynakologischen Praxis. Ther Gegenwart 116: 2305–2312
Beck H, Beck K (1982) Schaufenster (Suppl Deutsche Apotheker Zeitung) 31: 33–34
Becker GL (1952) The case against mineral oil. Am J Dig Dis 19: 344–348
Bennett A (1992) Control of gastrointestinal motility. In: Capasso F, Mascolo N (eds) Natural drugs and the digestive tract. EMSI, Rome, pp 1–5
Bennett A, Eley KG (1976) Intestinal pH and propulsion: an explanation of diarrhea in lactose deficiency and laxation by lactulose. J Pharm Pharmacol 28: 192–195
Bennett PN (1988) Drugs and human lactation. Elsevier, New York, NY
Bennett WG, Cerda JJ (1996) Dietary fibers: Fact and fiction. Dig Dis 14: 43–58
Benveniste J (1988) PAF-acether, an other phospholipid with biological activity. In: Karnovsky ML, Leaf A, Bolis LC (eds) Biological membranes. Liss, New York, pp 73–85
Berridge M (1983) Phosphatidylinositol hydrolysis: a general transducing mechanism of calcium-mobilizing receptors. In: Turnberg LA (ed) Intestinal secretion. Knapp Drewett and Sons, Great Britain, pp 28–34
Beubler E (1985) Influence of chronic bisacodyl treatment on the effect of acute bisacodyl on water and electrolyte transport in the rat colon. J Pharm Pharmacol 37: 131–133
Beubler E, Juan N (1978) PGE-mediated laxative effect of diphenolic laxatives. Naunyn Schmiedeberg’s Arch Pharmacol 305: 241–246
Beubler E, Juan N (1979) Effect of ricinoleic acid and other laxatives on net water flux and prostaglandin E release by the rat colon. J Pharm Pharmacol 31: 681–685
Beubler E, Kollar G (1985) Stimulation of PGE2 synthesis and water and electrolyte secretion by senna anthraquinones is inhibited by indomethacin. J Pharm Pharmacol 32:248–251
Binder HJ (1989) Absorption and secretion of water and electrolytes by small and large intestine. In: Sleisenger MH, Fordtran JS (eds) Gastrointestinal disease, 4th ed. Saunders, Philadelphia, pp 1022–1045
Binder HJ (1977) Pharmacology of laxatives. Annu Rev Pharmacol Toxicol 17: 355–367
Binder HJ (1988) Use of laxatives in clinical medicine. Pharmacology 36 (Suppl 1): 226–229
Boisson J (1990) Essai du Duphalac (lactulose) pour le sevrage de laxatifs irritants. Le Concours Medical 10: 112–132
Bolton J, Field M (1977) Ca ionophore stimulated ion secretion in rabbit ileal mucosa: relations to actions of cyclic 3′, 5′-AMP and carbamylcholine. J Membr Biol 35: 159–163
Boyd JT, Doll R (1954) Gastro-intestinal cancer and the use of liquid paraffin. Br J Cancer 8: 231–237
Bretagne J, Vidon N, L’Hirondel C, Bernier JJ (1981) Increased cell loss in the human jejunum induced by laxatives (ricinoleic acid, dioctyl sodium sulphosuccinate, magnesium sulphate, bile salts). Gut 22: 264–269
Brooks SJH (1993) Neuronal nitric oxide in the gut. J Gastroenterol Hepatol 8: 590–593
Brown JP, Brown RJ (1976) Mutagenesis by 9,10 anthraquinone derivatives and related compounds in Salmonella thyphimurium. Mutat Res 40: 203–224
Brunton LL (1990) Agents affecting gastrointestinal water flux motility, digestants and bile acids. In: Goodman Gilman A, Rall TW, Nies AS, Taylor P (eds) The pharmacological basis of therapeutics, 8th edn. Pergamon Press, New York, pp 914–932
Brusick D, Mengs U (1997) Assessment of the genotoxic risk from laxative senna products. Environ Mol Mutagen 29: 1–9
Buckley TL, Hoult JRS (1989) Platelet activating factor is a potent colonic secretagogue with actions independent of specific PAF receptors. Eur J Pharmacol 163: 273–283
Bueno L, Frexinos J, Fioramonti J (1988) Role of motility in pathogenesis of constipation and diarrhea. Pharmacology 36 (Suppl 1): 15–22
Burgess DE (1972) Constipation in obstetrics. In: Jones FA, Godding EW (eds) Management of constipation. Blackwell Scientific, Oxford, pp 176–188
Cameron BD, Phillips MWA, Fenerty CA (1988) Milk transfer of rhein in the rhesus monkey. Pharmacology 36 (Suppl 1): 221–225
Campbell CM, Detwiller AK (1930) The lazy colon. Newer methods and latest advances of science in the treatment of constipation, 7th edn. The Educational Press, New York, p 312
Campbell-Mackie M (1963) The re-educative treatment of bowel dysfunction in infant and children. S Afr Med J 37: 675–678
Capasso F (1993) Lassativi e purganti. Aboca, Sansepolcro, pp 21 and 104
Capasso F, Tavares IA, Tsang R, Bennett A (1985) The role of calcium on eicosanoid production induced by ricinoleic acid or the calcium ionophore A23187. Prostaglandins 30: 119–124
Capasso F, Mascolo N, Autore G, Romano V (1986) Laxatives and the production of autacoids by rat colon. J Pharm Pharmacol 38: 627–629
Capasso F, Tavares IA, Bennett A (1992) PAF formation by human gastrointestinal mucosa/submucosa in vitro: release by ricinoleic acid and inhibition by 5-aminosalicylic acid. J Pharm Pharmacol 44: 771–772
Capasso F, Izzo AA, Mascolo N, Autore G, Di Carlo G (1993) Effect of senna is not mediated by platelet-activating factor. Pharmacology 47 (Suppl 1): 58–63
Capasso F, Di Carlo R (1994) Purganti, lassativi ed antidiarroici. In: Giotti A et al (eds) Farmacologia clinica e chemioterapia, 3a ed, Vol 1. UTET, Torino, pp 1227–1231
Capasso F, Mascolo N, Izzo AA, Gaginella TS (1994) Dissociation of castor oil-induced diarrhea and intestinal mucosal injury in rat: effect of NG-nitro-L-arginine methyl ester Br J Pharmacol 113: 1127–1130
Caren JF, Meyer JH, Grossman MI (1974) Canine intestinal secretion during and after rapid distension of the small bowel. Am J Physiol 227: 183–188
Case RM, Hardcastle J, Hardcastle PT (1983) Calcium and secretory process. In: Turnberg LA (ed) Intestinal Secretion. Knapp Drewett and Sons, Great Britain, pp 24–28
Christensen J (1987) Motility of the colon. In: Johnson LR (ed) Physiology of the gastrointestinal tract, 2nd edn. Raven Press, New York, pp 665–693
Cline WS, Lorenzsonn V, Benz L, Bass P, Olsen WA (1979) The effects of sodium ricinoleate on small intestinal function and structure. J Clin Invest 58: 380–390
Code CF, Bass P, McClary GB Jr, Newnum RL, Orvin AL (1960) Absorption of water, sodium and potassium in small intestine of dogs. Am J Physiol 199: 281–288
Colombo P (1994) Trattamento della stipsi cronica in soggetti anziani. Arch Med Interna 46: 1–17
Corbett CL, Issacs PET, Riley AK, Turnberg LA (1977) Human intestinal transport in vitro. Gut 18: 136–140
Cummings JH (1974) Progress report: Laxative abuse. Gut 15: 758–766
Cummings JW (1978) Dietary fibre and colonic function. J R Soc Med 71: 81–86
Dawson JR, Schwenk M (1989) Isolated epithelial cells. Progress in Pharmacol Clin Pharmacol 7: 21–41
De Jonge HR (1975) The response of small intestine villous and crypt epithelium to cholera-toxin in rat and guinea-pig. Evidence against a specific role of the crypt cells in choleragen-induced secretion. Biochim Biophys Acta 381: 128
de Witte P, Dreessen M, Lemli J (1991) The influence of some anthracene and diphenylmethane derivatives on water and electrolyte movement in rat colon. Pharm Acta Helv 66: 70–73
De Wolf FA, Edelbrock PM, de Haas EJM, Vermeij P (1983) Experience with a screening method for laxative abuse. Hum Toxicol 2: 385–389
Di Palma JA, Brady CE (1989) Colon cleansing for diagnostic and surgical procedures: Polyethylene glycol-electrolyte lavage solution. Am J Gastroenterol 84: 1008–1016
Dobb GJ, Edis RH (1984) Coma and neuropathy after ingestion of herbal laxative containing podophyllin. Med J Aust 140: 495–496
Dolman D, Edmonds CJ (1975) The effect of aldosterone and the renin angiotensin system on sodium, potassium and chloride transport by proximal and distal rat colon in vivo. J Physiol (Lond) 250: 597–611
Donowitz M, Welsh MJ (1987) Regulation of mammalian small intestinal electrolyte secretion. In: Johnson LR (ed) Physiology of the gastrointestinal tract, 2nd edn. Raven Press, New York, pp 1351–1388
Douthwaith A, Goulding R (1957) Action of senna. Br Med J 4: 1414–1415
Dreessen M, Lemli J (1988) Studies in the field of drugs containing anthraquinone derivatives. The metabolism of cascarosides by intestinal bacteria. Pharm Acta Helv 63: 287–289
Dubecq JP, Palmade JL (1974) Etude de l’administration de Tamarine chez la mère qui allaite. Gaz Med Fr 81: 5173–5175
Dufour P, Gendre P (1984) Ultrastructure of mouse intestinal mucosa and changes observed after long-term anthraquinone administration. Gut 15: 1358–1363
Dufour P, Gendre P (1988) Long-term mucosal alterations by sennosides and related compounds. Pharmacology 36 (Suppl 1): 194–202
Duncan AS (1957) Standardized senna as a laxative in the puerperium. A clinical assessment. Br Med J 1:439–441
Ewe K (1987) Effect of bisacodyl on intestinal electrolyte and water net transport and transit. Digestion 37: 247–253
Faber P, Strenge-Hesse A (1988) Relevance of rhein excretion into breast milk. Pharmacology 36 (Suppl 1): 212–220
Farack U, Nell G (1984) Mechanism of action of diphenolic laxatives: The role of adenylate cyclase and mucosal permeability. Digestion 30: 191–194
Farack U, Gruber E, Loeschke K (1985) The influence of bisacodyl on mucus secretion, mucus synthesis and electrolyte movements in the rat colon in vivo. Eur J Pharmacol 117: 215–222
Ferlemann G, Vogt W (1965) Entazetylierung und Resorption von phenolischen Laxantien. Arch Exp Path Pharmak 250: 479–487
Field M, Smith PL, Bolton JE (1980) Ion transport across the isolated small intestinal mucosa of the winter flounder Pseudopleuronectes american: II Effects of cyclic AMP. J Membr Biol 55: 157
Fingl E (1975) Laxatives and cathartics. In: Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 5th edn. Macmillan, New York, pp 976–986
Fireman Z, Rozen P, Fine N, et al. (1989) Reproducibility studies and effects of bowel preparation on measurements of rectal epithelial proliferations. Cancer Lett 45: 59–64
Fleischer N, Brown H, Graham DY, Delena S (1969) Chronic laxative-induced hyperaldosteronism and hypokalemia stimulating Bartter’s syndrome. Ann Intern Med 70: 791–798
Fleming BJ, Genuth SM, Gould AB, Kaminonkowski MD (1975) Effects of potassium and sodium replacement on the renin-angiotensin-aldosterone system. Ann Int Med 83: 60–62
Forman DT, Garvin JE, Forestner JE, Taylor CB (1968) Increased excretion of fecal bile acids by an oral hydrophilic colloid. Proc Soc Exp Biol Med 127: 1060–1063
Forth W, Rummel W, Baldauf J (1966) Wasser — und Elektrolytbewegung am Dünn — und Dickdarm unter dem Einfluss von Laxantien, ein Beitrag zur Klärung ihres Wirkungsmechanismus. Arch Pharmak Exp Path 254: 18–32
Freiman DG, Engelberg H, Merrit WH (1940) Oil aspiration pneumonia in adults: a study of 47 patients. Arch Intern Med 66: 11–38
Frexinos J, Staumont G, Fioramonti J, Bueno L (1989) Effects of sennosides on colonic myoelectrical activity in man. Dig Dis Sci 34: 214–219
Gaginella TS (1977) The management of gastrointestinal disorders. II. Use and misuse of laxatives. J Continuing Education of Pharmacy 1: 19–28
Gaginella TS (1990a) Eicosanoid-mediated intestinal secretion. In: Lebenthal E, Duffey M (eds) Secretory diarrhea. Raven Press, New York, pp 15–30
Gaginella TS (1990b) Receptor pharmacology of intestinal secretion. In: Lebenthal E, Duffey M (eds) Secretory diarrhea. Raven Press, New York, pp 163–178
Gaginella TS (1995a) Laxative drugs. In: Munson PL, Mueller RA and Breese GR (eds) Principles of Pharmacology. Chapman and Hall, New York
Gaginella TS (ed) (1995b) Handbook of methods in gastrointestinal pharmacology. CRC Press, Boca Raton
Gaginella TS, Bass P (1978) Laxatives: An uptade on mechanism of action. Life Sci 23: 1001–1010
Gaginella TS, Phillips SF (1975) Ricinoleic acid: current view of an ancient oil. Am J Dig Dis 20: 1171–1177
Gaginella TS, Hubel KA, O’Dorisio TM (1982) Vasoactive intestinal polypeptide and intestinal chloride secretion. In: Vasoactive intestinal polypeptide. Adv Peptide Hormone Res, vol 1. Raven Press, New York, pp 211–222
Gaginella TS, Mascolo N, Izzo AA, Autore G, Capasso F (1994) Nitric oxide as a mediator of bisacodyl and phenophthalein laxative action: induction of nitric oxide synthase. J Pharmacol Exp Ther 270: 1239–1245
Garcia-Villar R, Leng-Peschlow E, Ruckebusch Y (1980) Effect of anthraquinone derivatives on canine and rat intestinal motility. J Pharm Pharmacol 32: 323–329
Gattuso JM, Kamm MA (1994) Adverse effects of drugs used in the management of constipation and diarrhoea. Drug Saf 10: 47–65
Geboes K, Nijs G, Mengs U, Geboes KPJ, Van Damme A, de Witte P (1993) Effects of contact laxatives on intestinal and colonic epithelial cell proliferation. Pharmacology 47 (Suppl 1): 187–195
Ghadially FN, Parry EW (1966) An electro-microscope and histochemical study of melanosis coli. J Pharm Bact 92: 313–317
Gobel D (1978) Melanosis coli. Med Klin 73: 519–523
Grindlay D, Reynolds T (1986) The Aloe vera phenomenon: a review of the properties and modern uses of the leaf parenchyma gel. J Ethnopharmacology 16: 117–151
Gullikson GW, Bass P (1984) Mechanisms of action of laxative drugs. In: Csaky TZ (ed) Pharmacology of intestinal permeation II, vol 70. Springer-Verlag, Berlin Heidelberg New York, pp 419–459
Hattori M, Kim G, Motoike S, Kobashi K, Namba T (1982) Metabolism of sennosides by intestinal flora. Chem Pharm Bull (Tokyo) 30: 1338–1346
Hardcastle JD, Wilkins JL (1970) The action of sennosides and related compounds on human colon and rectum. Gut 11: 1038–1040
Harvey RE, Read AE (1973) Saline purgatives act by releasing cholecystokinin. Lancet 2: 185–187
Harvey RE, Read AE (1975) Mode of action of saline purgatives. Am Heart J 89: 810–812
Haubrich WS (1985) Constipation. In: Bockus J (ed) Gastroenterology. Saunders, Philadelphia, pp 111–124
Haward LRC, Hughes-Roberts HE (1962) The treatment of constipation in mental hospitals. Gut 3: 85–90
Heaton KW (1972) Bile salts in health and disease. Churchill Livingstone, Edinburgh
Heiny BM (1976) Langzeitbehandlung mit einem pflanzlichen Laxativum. Serumelektrolyte und Säurenhaushalt. Arztliche Praxis 28: 563–564
Hill MJ, Drasar BS, Williams REO, Meade TW, Cox AG, Simpson JEP, Morson BC (1975) Faecal bile-acids and Clostridia in patients with cancer of the large bowel. Lancet i: 535
Hietala P, Marvola M, Parviainen T, Lainonen H (1987) Laxative potency and acute toxicity of some anthraquinone derivatives, senna extracts and fractions of senna extracts. Pharmacol Toxicol 61:153–156
Hillestad B, Sund RB, Buajordet M (1982) Intestinal handling of bisacodyl and picosulphate by everted sacs of the rat jejunum and stripped colon. Acta Pharmacol Toxicol 51: 388–394
Hodgson J (1972) Effect of methylcellulose on rectal and colonic pressure in treatment of diverticular disease. Br Med J 3: 729–731
Hormann HP, Korting HC (1994) Evidence for the efficacy and safety of topical herbal drugs in dermatology: part 1: anti-inflammatory agents. Phytomedicine 1: 161–171
Husain A (1992) Economic aspects of exploitation of medicinal plants. In: Akerele O, Heywood V, Synge H (eds) Conservation of Medicinal Plants. University Press, Cambridge, pp 125–140
Illingworth RS (1953) Abnormal substances excreted in human milk. Practitioner 171: 533–538
Ishii Y, Tanizawa H, Takino Y (1990) Studies of Aloe III. Mechanism of cathartic effect. Chem Pharm Bull 38: 197–200
Itasaka S, Shirataori K, Takahashi T, Ishikawa M, Kanedo K, Suzuki Y (1992) Stimulation of intramural secretory reflex by luminal distension pressure in rat distal colon. Am J Physiol 263: G108–G114
Izzo AA (1996) PAF and the digestive tract. A review. J Pharm Pharmacol 48: 1103–1111
Izzo AA, Mascolo N, Autore G, Di Carlo G, Capasso F (1993) Increased ex-vivo colonic generation of PAF induced by diphenylmethane stimulant laxatives in the rat, mice, guineapig and rabbits. J Pharm Pharmacol 45: 916–918
Izzo AA, Gaginella TS, Mascolo N Capasso F (1994) Nitric oxide as a mediator of the laxative action of magnesium sulphate. Br J Pharmacol 113: 228–232
Izzo AA, Gaginella TS, Capasso F (1996a) The osmotic and intrinsic mechanisms of the pharmacological laxative action of oral high doses of magnesium sulphate. Importance of the release of digestive polypeptides and nitric oxide. Magnes Res 9: 133–138
Izzo AA, Gaginella TS, Mascolo N, Borrelli F, Capasso F (1996b) NG-Nitro-L-arginine methyl ester reduces senna- and cascara-induced diarrhoea and fluid secretion in the rat. Eur J Pharmacol 301: 137–142
Izzo AA, Sautebin L, Rombola L, Capasso F (1997) The role of constitutive and inducible nitric oxide synthase in senna- and cascara-induced diarrhoea in the rat. Eur J Pharmacol 323: 93–97
Jones FA, Gotting EW (1972) Management of constipation. Blackwell and Mott, Oxford Kacere RD, Srivatsa SS, Tremaine WJ, Ebnet LE, Batts KP (1993) Chronic diarrhea due to surreptitious use of bisacodyl: case reports and methods for detection. Mayo Clin Proc 68: 355–357
Kantor JL, Cooper LF (1937) The dietetic treatment of constipation with special reference to food fiber. Ann Intern Med 10: 965–978
Kawai K, Mori H, Sugie S, Yoshimi N, Inoue T, Nakamura T, Nozawa Y, Matsushima T (1986) Genetoxicity in the hepatocyte/DNA repair test and toxicity to liver mitochondria of 1-hydroxyanthraquinone and several dihydroxyanthraquinones. Cell Biol Toxicol 4: 457–467
Kellogg JH (1921) The new dietetics. Modern Medicine Publishing, Battle Creek
Kierman JA, Heinicke EH (1989) Sennosides do not kill myenteric neurons in the colon of the rat or mouse. Neuroscience 30: 837–842
Kinnunen O, Salokannel J (1987) Constipation in elderly long-stay patients: its treatment by magnesium hydroxide and bulk laxative. Ann Clin Res 19: 321–323
Kinnunen O, Winblad I, Koistinen P, Salokannel J (1993) Safety and efficacy of a bulk laxative containing senna versus lactulose in the treatment of chronic constipation in geriatric patients. Pharmacology 47 (Suppl 1): 253–255
Kleibeuker JH, Cats A, Zwart N, Mulder NH, Hardonk MJ, de Vries EGE (1995) Excessively high cell proliferation in sigmoid colon after an oral purge with anthraquinone glycosides. J Natl Cancer Inst 87: 152–153
Kluck P, ten Kate FJW, Schouten WR, Bartels KCM, Tibboel D, van der Kamp AWM, Molenaar JC, van Blankenstein M (1987) Efficacy of antibody NF2F11 staining in the investigation of severe long-standing constipation. Gastroenterology 93: 872–875
Koskela E, Kulju T, Collan Y (1989) Prevalence, distribution and histologic feature in 200 consecutive autopsies at Kuopio University Central Hospital. Dis Colon Rectum 32: 235–239
Krishnamurthy S, Schuffler MD, Rohrmann CA, Pope CE (1985) Severe idiopathic constipation is associated with a distinctive abnormality of the colonic myenteric plexus. Gastroenterology 88: 26–34
Kune GA (1993) Laxative use not a risk for colorectal cancer. Data from the Melbourne colorectal cancer study. Z Gastroenterol 31: 140–143
Kune GA, Kune S, Field B, Watson LF (1988) The role of chronic constipation diarrhoea, and laxative use in the etiology of large bowel cancer. Data from the Melbourne colorectal cancer study. Dig Colon Rect 31: 507–512
Larven A, Sloane A, Munch J (1952) Biossay of cathartics. I. Emodine type. J Am Pharm Assoc 41: 548–552
Lawson M, Kern F, Everson GT (1985) Gastrointestinal transit time in human pregnancy: proliferation by postpartum normalization. Gastroenterology 89: 996–999
Lemaitre G, L’Herminé C, Decoulx M, Houlcke M, Linquette M (1969) Les lesions coliques par abus de laxatifs. Presse Med 77: 393–394
Leng-Peschlow E (1980) Inhibition of intestinal water and electrolyte absorption by senna derivatives in rats. J Pharm Pharmacol 32: 330–335
Leng-Peschlow E (1986) Acceleration of large intestine transit time in rats by sennosides and related compounds. J Pharm Pharmacol 38: 369–373
Leng-Peschlow E (1992) Senna and its rational use. Pharmacology 44 (Suppl 1): 1–52
Leng-Peschlow E, Mengs U (1995) Senna laxatives: safe and effective. Pharmaz Zeit 140: 668–674
Leng-Peschlow E, Odenthal KP, Voderholzer W, Muller-Lissner S (1993) Chronic sennoside treatment does not cause habituation and secondary hyperaldosteronism in rats. Pharmacology 47 (Suppl 1): 162–171
Lesna M, Hamlyn AN, Venables CW, Record CD (1977) Chronic laxative abuse associated with pancreatic islet cell hyperplasia. Gut 18: 1032–1035
Levine D, Goode AW, Wingate DL (1981) Purgative abuse associated with reversible cachexia, hypogammaglobulinemia, and finger clubbing. Lancet 1: 919–920
Lium R, Florey HW (1939) The action of magnesium sulphate on the intestine of the cat. Quarterly J Exp Physiol 29: 303–319
Longo R (1980) Attività e metabolismo nel topo di componenti la corteccia di Rhamnusfrangula e di prodotti sintetici a struttura antrachinonica. Boll Chim Farm 119: 669–684
Lowy A (1960) Bowel reabilitation in the chronically constipated patient. Int Rec Med 173: 303–305
Lyden-Sokolowski A, Nilsson A, Sjoberg P (1993) Two-year carcinogenicity study with sennosides in the rat: emphasis on gastrointestinal alterations. Pharmacology 47: 209–215
Maenz DD, Forsyth GW (1982) Ricinoleate and deoxycholate are calcium ionophore in jejunal brush borders. J Memb Biol 70: 125–133
Mahon R, Palmade J (1974) Traitement de la constipation chez la femme enceinte. Gaz Med Fr 81: 3259–3260
Mascolo N, Autore G, Izzo AA, Biondi A, Capasso F (1992) Effects of senna and its active compounds rhein and rheinanthrone on PAF formation by rat colon. J Pharm Pharmacol 44: 693–695
Mascolo N, Gaginella TS, Izzo AA, Di Carlo G, Capasso F (1994a) Nitric oxide involvement in sodium choleate-induced fluid secretion and diarrhoea in rats. Eur J Pharmacol 264: 21–26
Mascolo N, Izzo AA, Autore G, Barbato F, Capasso F (1994b) Nitric oxide and castor oil-induced diarrhea. J Pharmacol Exp Ther 268: 291–295
Mascolo N, Izzo AA, Barbato F, Capasso F (1993) Inhibitors of nitric oxide synthase prevent castor oil-induced diarrhoea in rats. Br J Pharmacol 108: 861–864
Mascolo N, Izzo AA, Gaginella TS, Capasso F (1996) Relationship between nitric oxide and platelet activating factor in castor oil-induced mucosal injury in the rat duodenum. Naunyn Schmiedebergs Arch Pharmacol 353: 680–684
Mascolo N, Meli R, Autore G, Capasso F (1988a) Senna still causes laxation in rats maintained on a diet deficient in essential fatty acids. J Pharm Pharmacol 40: 882–884
Mascolo N, Meli R, Autore G, Capasso F (1988b) Evidence against a dependence of the senna effect on prostaglandin formation. Pharmacology 36 (Suppl 1): 92–97
McCance RA, Widdowson WM (1955) Old thoughts and new work on bread white and brown. Lancet 2: 205–210
Mc Clure Browne JC, Edmunds V, Fairbairn IW, Reid DD (1957) Clinical and laboratory assessments of senna preparation. Br Med J 1: 436–439
McConnell AA, Eastwood MA, Mitchell WD (1974) Physical characteristics of vegetable foodstuffs that could influence bowel function. J Sci Food Agric 25: 1457–1464
Mc Naughton WK, Gall DG (1991) Mechanisms of platelet activating factor-induced electrolyte transport in the rat jejunum. Eur J Pharmacol 200: 17–23
Meisel JL, Bergman D, Graney D, Saunders DR, Rubin LE (1977) Human rectal mucosa: proctoscopic and morphological changes caused by laxatives. Gastroenterology 72: 1274–1279
Mereto E, Ghia M, Brambilla G (1996) Evaluation of the potential carcinogenic activity of senna and cascara glycosides for the rat colon. Cancer Lett 101: 79–83
Milner P, Belai A, Tomlinson A, Hoyle CV, Sarner S, Burnstock G (1992) Effect of long-term laxative treatment on neuropeptides in rat mesenteric vessels and caecum. J Pharm Pharmacol 44: 777–779
Moreto M, Gonalons E, Mylonakis N, Giraldes A, Torralba A (1979) 3,3-bis-(4-hydroxyphenyl)-7-methyl-2-indolinone (BHMI), the active metabolite of the laxative sulisatin. Arzneimittelforschung 29: 1561–1564
Moriarty KJ, Dawson AM (1984) Use and abuse of cathartics. In: Csaky TZ (ed) Pharmacology of intestinal permeation II. vol 70. Springer-Verlag, Berlin Heidelberg New York, pp 509–531
Moriarty KJ, Silk D (1988) Laxative abuse. Dig Dis Sci 6: 15–29
Mori H, Sugie S, Niwa K, Takahashi M, Kawai K (1985) Induction of intestinal tumors in rat by chrysazin. Br J Cancer 52: 781–783
Mori H, Sugie S, Niwa K, Yoshimi N, Tanaka T, Hirono I (1986) Carcinogenicity of chrysazin in large intestine and liver of mice. Jpn J Cancer Res 77: 871–876
Mori H, Yoshimi N, Iwata H, Mori Y, Hara A, Tanaka T, Kawai K (1990) Carcinogenicity in rats: induction of large bowel liver and stomach neoplasms. Carcinogenesis 11: 799–802
Muller SO, Eckert I, Lutz WK, Stopper H (1996) Genotoxicity of the laxative drug components emodin, aloe-emodin and danthron in mammalian cells: Topoisomerase II mediated? Mutat Res Genet Toxicol 371: 165–173
Muller-Lissner SA (1993) Adverse effects of laxatives: fact and fiction. Pharmacology 47: 138–145
Muller-Lissner SA (1993) Laxative-induced damage to the colon. In: Guslandi M, Braga PC (eds) Drug-induced injury to the digestive system. Springer-Verlag, Berlin Heidelberg New York, pp 131–142
Munch JC, Calesnick B (1960) Laxative studies. Human threshold doses of white and yellow Phenolphthalein. Clin Pharmacol Ther 1: 311–315
Nakamura GJ, Schneiderman LJ, Klauber MR (1984) Colorectal cancer and bowel habits. Cancer 54: 1475–1477
Nell G, Rummell W (1984) Action mechanisms of secretagogue drugs. In: Csaky TZ (ed) Pharmacology of intestinal permeation II, vol 70. Springer-Verlag, Berlin Heidelberg New York, pp 461–508
Newal CA, Anderson LA, Phillipson JD (1996) Herbal Medicines. The Pharmaceutical Press, London
Nijs G, de Witte P, Lemli J (1991) Role of prostaglandin E2 in the secretion caused by rheinanthrone and rhein anthraquinone in the small intestine. Gastroenterology 100: A698
Nishioka I (1985) Discovery of new biological activities and the active components in rhubarb. In: Takemi T, Hasegava M, Kumagai A, Otsuga Y (eds) Herbal Medicine: kampo, past and present. Tsumura Juntendo Inc, Tokio, pp 41–51
Nusko G, Schneider B, Muller G, Kusche J, Hahn EG (1993) Retrospective study on laxative use and melanosis coli as risk factors for colorectal neoplasma. Pharmacology 47 (Suppl 1): 234–241
Odenthal K, Ziegler D (1988) In vitro effects of anthraquinones on rat intestine and uterus. Pharmacology 36 (Suppl 1): 57–65
Ornstain MH, McLain Baird I (1987) Dietary fiber and the colon. Mol Aspects Med 9: 41–67
Osten JR, Naterson BJ, Rogers AJ (1980) Laxative abuse syndrome. Am J Gastroenterol 74: 451–458
Painter NS, Almeida AZ, Colebourne KW (1972) Unprocessed bran in treatment of diverticular disease of the colon. Br Med J 1: 137–140
Parry E, Shields R, Turnbull AC (1970) Transit time in the small intestine in pregnancy. J Obstet Gynaecol Br Commow 77: 900–901
Parsons DS (1968) Methods for the investigations of intestinal absorption. In: Code CF (ed) Handbook of physiology, alimentary canal, vol III. American Physiological Society, pp 1177–1216
Passmore AP, Wilson-Davies K, Stoker C, Scott ME (1993) Chronic constipation in long stay elderly patients: a comparison of lactulose and senna-fiber combination. Br Med J 307: 769–771
Phillips SF, Gaginella TS (1977) Intestinal secretion as a mechanism in diarrheal disease. In: Jerzy-Glass GB (ed) Progress in gastroenterology, vol III. Grune and Stratton, New York, pp 481–504
Pinto A, Calignano A, Mascolo N, Autore G, Capasso F (1989) Castor oil increases intestinal formation of platelet activating factor and acid phosphatase release in the rat. Br J Pharmacol 96: 872–874
Powell DW (1983) Neurohumoral control of intestinal secretion. In: Turnberg LA (ed) Intestinal secretion. Knapp Drewett and Sons, Great Britain, pp 42–45
Prochnow L(1911) Experimentelle Beiträge zur Kenntnis der Wirkung von Volksabortiva. Arch Int Pharmacodyn 21: 313–319
Racagni G, Cantaluppi S, Fumagalli R (1986) Farmacologia generale ed applicata. Masson, Milano, p 749
Rachmilewitz D, Karmeli F, Okon E (1980) Effects of bisacodyl on cAMP and prostaglandin E2 contents, Na-K-ATPase, adenylylcyclase, and phosphodiesterase of rat intestine. Dig Dis Sci 25: 602–608
Rask-Madsen J, Bukhave K (1981) The role of prostaglandins in diarrhoea. Clin Res Rev 1 (Suppl 1): 33–48
Rask-Madsen J, Bukhave K (1983) Prostaglandins and intestinal secretion. In: Turnberg LA (ed) Intestinal secretion, Knapp Drewett and Sons, Oxford, pp 76–83
Rawson MD (1966) Cathartic colon. Lancet 1: 1121–1124
Refit (1996) Repertorio fitoterapico. OEMF, Milano
Riemann JF, Schenk J, Ehler R, Schmidt H, Koch H (1978) Ultrastructural changes of colonic mucosa in patients with chronic laxative misuse. Acta Hepato-Gastroenterol 25: 213–218
Riemann J, Schmidt H, Zimmerman W (1980) The fine structure of colonic submucosal nerves in patients with chronic laxative abuse. Scand J Gastroenterol 15: 761–768
Robbers JE, Speedie MK, Tyler VE (1996) Pharmacognosy and pharmacobiotechnology. Williams and Wilkins, Baltimore, p 51
Roggin GH, Banwell JG, Yardley JH, Hendrix TH (1972) Unimpaired response of rabbit jejunum to cholera toxin after selective damage in villus epithelium. Gastroenterology 63: 981
Roncucci L, Di Donato P, Carati L, Ferrari A, Perini M, Bertoni G, Bedogni G, Paris B, Svanoni F, Girola M (1993) Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Dig Colon Rectum 3: 227–234
Rondanelli R, Autelli F, Guaglio R (1980) Valutazione delle interazioni nelle associazioni tra farmaci. Bertolli A, Mascherpa P, Storti E (eds). ESAM, Roma
Rosprich G (1980) Dauerbehandlung mit Laxantien. Therapiewoche 30: 5836–5837
Rudolph RL, Mengs U (1988) Electron microscopical studies on rat intestine after long-term treatment with sennosides. Pharmacology 36 (Suppl 1): 188–193
Sarna K, Otterson M (1988) Gastrointestinal motility: some basic concepts. Pharmacology 36 (Suppl 1): 7–14
Sarner M (1976) Problems caused by laxatives. Practic 216: 661–664
Saunders DR, Sillery J, Rachmilewitz D (1975) Effect of dioctyl sodium sulpho-succinate on structure and function of rodent and human intestine. Gastroenterology 69: 380–386
Saunders DR, Sillery J, Rachmilewitz D, Rubin CE, Tytgat GN (1977) Effect of bisacodyl on the structure and function of rodent and human intestine. Gastroenterology 72: 849–856
Saunders DR, Sillery J, Surawica C, Tytgat GN (1978) Effect of Phenolphthalein on the function and structure of iodent and human intestine. Dig Dis Sci 23: 909–913
Schmidt A, Von Noorden C (1936) Klinik der Darmkrankheiten, 2nd edn. Bergmann, Munich, p 382
Schultz SG, Zalusky R (1964) Ion transport in isolated rabbit ileum. I. Short-circuit current and Na+ fluxes. J Gen Physiol 47: 567–584
Schwartz WB, Relman AS (1953) Metabolic and renal studies in chronic potassium depletion resulting from overuse of laxatives. J Clin Invest 32: 258–271
Scott RS (1965) Management of constipation in obstetrics: A clinical report on 592 cases. West Med 6: 342–344
Shelton MG (1980) Standardized senna in the management of constipation in the Puerperium. S Afr Med J 57: 78–80
Siegers CP (1992) Anthranoid laxatives and colorectal cancer. Trends Pharmacol Sci 13: 229–231
Siegers CP, von Hertzberg Lottin E, Otte M, Scheider B (1993) Anthranoid laxative abuse — a risk for colorectal cancer? Gut 34: 1099–1101
Smith B (1968) Effect of irritant purgatives on the myenteric plexus in man and the mouse. Gut 9: 139–143
Smith B (1973) Pathologic changes in the colon produced by anthraquinone purgatives. Dis Colon Rectum 16: 455–458
Smith CW, Evans PR (1961) Bowel motility. A problem in institutionalized geriatric care. Geriatrics 16: 189–192
Sonnenberg A, Muller AD (1993) Constipation and cathartics as risk factors of colorectal cancer: a meta-analysis. Pharmacology 47 (Suppl 1): 224–233
Speare GS (1951) Melanosis coli. Experimental observation on its production and elimination in twenty-three cases. Am J Surg 82: 631–637
Spiessens C (1991) Morphological and functional changes induced by laxatives in the intestinal mucosa. Thesis, Katholicke Universiteit, Leuven, p 145
Spiessens C, de Witte P, Geboes K, Lemli J (1991) Experimental induction of pseudomelanosis coli by anthranoid laxatives and non-anthranoid laxatives. Pharmaceut Pharmacol Lett 1: 3–6
Staumont G, Fioramonti J, Frexinas J, Bueno L (1988) Changes in colonic motility induced by sennosides in dogs: evidence of a prostaglandin mediation. Gut 29: 1180–1187
Steer HW, Colin-Jones DG (1975) Melanosis coli: studies on the toxic effects of irritant purgatives. J Pathol 115: 199–205
Stewart JJ, Gaginella TS, Bass P (1975a) Action of ricinoleic acid and structurally related fatty acids on the gastrointestinal tract. Effects on smooth muscle contractility in vitro. J Pharmacol Exp Ther 195: 347–354
Stewart JJ, Gaginella TS, Olsen WA, Bass P (1975b) Inhibitory actions of laxatives on motility and water and electrolyte transport in the gastrointestinal tract. J Pharmacol Exp Ther 192: 458–467
Sund RB, Lauterbach F (1986) Drug metabolism and metabolite transport in the small and large intestine: experiments with 1-naphthol and Phenolphthalein by luminal and contraluminal administration in the isolated guinea pig mucosa. Acta Pharmacol Toxicol 58: 74–83
Sund RB, Lauterbach F (1987) 1-Naphthol metabolism and metabolite transport in the small and large intestine. Effects of sulphate and phosphate ion omission, and of 2,6-dichloro-4-nitrophenol in the isolated guinea pig mucosa. Pharmacol Toxicol 60: 262–268
Sund RB (1989) Pharmacokinetics of diphenolic laxatives. A status report. In: Koster AS, Richter E, Lauterbach F, Hartmann F (eds) Progress in pharmacology and clinical pharmacology, vol 7/2. Gustav Fischer Verlag, Stuttgart, pp 300–310
Tamai H, Gaginella TS (1993) Direct evidence for nitric oxide stimulation of electrolyte secretion in the rat colon. Free Radic Res Comm 19: 229–239
Thompson GW (1979) The irritable gut, functional disorders of the alimentary canal. University Park Press, Baltimore, p 275
Thompson WG (1980) Laxatives: Clinical pharmacology and rational use. Drugs 19: 49–58
Tidmarsh CJ (1936) Chronic indigestion. Longman’s Green, Toronto, p 143
Tikkanen L, Matsushima T, Natoris S (1983) Mutagenicity of anthraquinones in the salmonella pre-incubation test. Mutat Res 116: 297–304
Tonini M, Costa M (1990) A pharmacological analysis of the neuronal circuitry involved in distension-evoked enteric excitatory reflex. Neuroscience 38: 787–795
Toyoda K, Nishikawa A, Furukawa F, Kawanishi T, Hayashi Y, Takahashi M (1994) Cell proliferation induced by laxatives and related compounds in the rat intestine. Cancer Lett 83: 43–49
Travell J (1954) Pharmacology of stimulant laxatives. Ann NY Acad Sci 58: 416–425
Turnberg LA, Bieberdort FA, Morawski SG, Fordtran JS (1970) Interrelationship of chloride bicarbonate, sodium and hydrogen transport in the lumen ileum. J Clin Invest 49: 557–561
Tyler VE, Brady LR, Robbers JE (1988) Pharmacognosy, 9th edn. Lea and Febinger, Philadelphia, pp 60–62
Tyler VE (1994) Herbs of choice. The therapeutic use of phytomedicinals. Pharmaceut Products Press, New York, pp 39–71
Tytgat GNJ, Mathus-Vliegen L (1983) Laxatives-laxative abuse-cathartic colon. J Drug Res 8: 1844–1850
Tzavella K, Schenkirsch S, Riepl RL, Odenthal KP, Leng-Peschlow (1995) Effect of long-term treatment with anthranoids and sodium picosulphate on the contents of vasoactive intestinal polypeptide, somatostatin and substance P in the rat colon. Eur J Gastroenterol Hepatol 7: 13–20
Ussing HH, Zehran K (1951) Active transport of sodium as the source of electric current in the short-circuit isolated from skin. Acta Physiol Scand 23: 110–127
Vago O (1969) Toxische und kaustische Komplikationen durch Gebrauch sogenannter fruchtabtreibender Arzneimittel. Z Geburtshilfe Gynakol 170: 272–277
Verhaeren E (1980) Mitochondrial uncoupling activity as a possible base for a laxative and antipsoriatic effect. Pharmacology 20 (Suppl 1): 43–49
Wager HP, Melosh WD (1958) The management of constipation in pregnancy. Q Rev Surg 15: 30–34
Wald A, van Thield DH, Hoechstaller L, Gavaler JS, Egler KM, Varm R, Scott L, Lester R (1982) Effect of pregnancy on gastrointestinal tract. Dig Dis Sci 27: 1015–1018
Wallace JL, Whittle BJR (1986) Profile of gastrointestinal damage induced by platelet-activating factor. Prostaglandins 32: 127–141
Wanitschke R (1980) Influence of rhein on electrolyte and water transfer in the isolated rat colonic mucosa. Pharmacology 20 (Suppl 1): 21–26
Wanitschke R (1987) Konsequenzen des Laxanzienabusus. Int Welt 5: 113–118
Weisbroadt NW (1987) Motility of the small intestine. In: Johnson LR (ed) Physiology of the gastrointestinal tract, 2nd edn. Raven Press, New York, pp 631–664
Werthmann MW, Krees SV (1973) Quantitative excretion of senokot in human breast milk. Med Ann Distr Columbia 42: 4–5
Westendorf J, Marquardt H, Poginsky B, Dominiak M, Shmidt J, Marquard H (1990) Genotoxicity of naturally occurring hydroxyanthraquinones. Mutat Res 340: 1–12
Wichtl M (1984) Teedrogen. Wisswnschaftliche Verlag-Gesellschaft, Stuttgart, pp 311–314
Wittoesch JH, Jackman RJ, Mc Donald JR (1958) Melanosis coli. General review and a study of 887 cases. Dis Colon Rectum 1: 172–180
Yagi T, Miyawaki Y, Nishikawa T, Yamauchi K, Kuwano S (1988) Involvement of prostaglandin E-like material in the purgative action of rheinanthrone, the intraluminal active metabolite of sennosides A and B in mice. J Pharm Pharmacol 40: 27–30
Yang K, Fan K, Mengs U, Lipkin M (1993) Effects of sennosides and non-anthranoid laxatives on cytochemistry of epithelial cells in rat colon. Pharmacology 47 (Suppl 1): 196–204
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Italia, Milano
About this chapter
Cite this chapter
Capasso, F., Gaginella, T.S. (1997). References. In: Laxatives. Springer, Milano. https://doi.org/10.1007/978-88-470-2227-0_11
Download citation
DOI: https://doi.org/10.1007/978-88-470-2227-0_11
Publisher Name: Springer, Milano
Print ISBN: 978-3-540-75037-6
Online ISBN: 978-88-470-2227-0
eBook Packages: Springer Book Archive